HLA-A Antikörper

Produktnummer ABIN7839650

Der Maus Monoklonal anti-HLA-A Antikörper (Klon W6132) (ABIN7839650) detektiert spezifisch HLA-A in FACS und IF. Dieser Antikörper reagiert spezifisch mit Proben aus Human.

Kurzübersicht für HLA-A Antikörper (ABIN7839650)

Target: HLA-A (Major Histocompatibility Complex, Class I, A (HLA-A))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser HLA-A Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), Immunofluorescence (IF)

Klon: W6132

Produktdetails anti-HLA-A Antikörper

Verwendungszweck: Mouse monoclonal antibody to HLA-A/B/C

Spezifität: Recognizes human HLA-A/B/C

Aufreinigung: The antibody was purified by affinity chromatography.

Anwendungsinformationen

Applikationshinweise: IF/IC (1/50 - 1/200), FC (1/500 - 1/2000)

Protokoll: 1. Take 100 μL peripheral blood anticoagulated by EDTA and add to the bottom of 5 mL tube. 2. Add appropriate amount of antibody to the bottom of flow tube mixing with the whole blood, incubate for 30 minutes at room temperature. 3. Add 2 mL RBC lysis buffer, incubate for 10 minutes after mixing, dissolve red blood cells. 4. Sample tube is set to 1000 rpm centrifugation for 5 minutes, discard the supernatant. 5. Add 2 mL PBS wash buffer to resuspend the cells, then 1000 rpm centrifugation for 5 minutes, discard the supernatant. 6. Add appropriate amount of fluorescent-labeled anti-mouse IgGs and incubate for 20 minutes away from light at room temperature. 7. Add 2 mL PBS wash buffer to resuspend the cells, then 1000 rpm centrifugation for 5 minutes, discard the supernatant. 8. Add 0.5 mL PBS wash buffer to resuspend the cells and detect by flow cytometry (sample should be determined on the day on the machine and can also be added fixation overnight at 4 °C then measured).

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Liquid in PBS, pH 7.3, and 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.

Details zu HLA-A

Target: HLA-A (Major Histocompatibility Complex, Class I, A (HLA-A))

Andere Bezeichnung: HLA-A

Hintergrund: HLA-A, HLAA, HLA class I histocompatibility antigen, A-68 alpha chain, Aw-68, HLA class I histocompatibility antigen, A-28 alpha chain, MHC class I antigen A*68, HLA-A, HLAA, HLA class I histocompatibility antigen, A-2 alpha chain, MHC class I antigen A*2, HLA-A, HLAA, HLA class I histocompatibility antigen, A-3 alpha chain, MHC class I antigen A*3, HLA-A, HLAA, HLA class I histocompatibility antigen, A-24 alpha chain, Aw-24, HLA class I histocompatibility antigen, A-9 alpha chain, MHC class I antigen A*24, HLA-A, HLAA, HLA class I histocompatibility antigen, A-32 alpha chain, MHC class I antigen A*32, HLA-A, HLAA, HLA class I histocompatibility antigen, A-69 alpha chain, Aw-69, HLA class I histocompatibility antigen, A-28 alpha chain, MHC class I antigen A*69, HLA-A, HLAA, HLA class I histocompatibility antigen, A-11 alpha chain, MHC class I antigen A*11, HLA-A, HLAA, HLA class I histocompatibility antigen, A-31 alpha chain, MHC class I antigen A*31, HLA-A, HLAA, HLA class I histocompatibility antigen, A-25 alpha chain, HLA class I histocompatibility antigen, A-10 alpha chain, MHC class I antigen A*25, HLA-A, HLAA, HLA class I histocompatibility antigen, A-1 alpha chain, MHC class I antigen A*1, HLA-A, HLAA, HLA class I histocompatibility antigen, A-26 alpha chain, MHC class I antigen A*26, HLA-A, HLAA, HLA class I histocompatibility antigen, A-34 alpha chain, Aw-34, HLA class I histocompatibility antigen, A-10 alpha chain, MHC class I antigen A*34, HLA-A, HLAA, HLA class I histocompatibility antigen, A-36 alpha chain, Aw-36, MHC class I antigen A*36

Gen-ID: 3105

UniProt: P04439

Pathways: T-Zell Rezeptor Signalweg, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response